Archive for January, 2014
Senesco Offers a New Approach to Cancer Treatment and Dr. Phillip Frost Is Now With the Company (SNTI, $5.31) (Subscribers Only)
Investment Overview Progress in the treatments of most cancers is a gradual and incremental process in which very few therapies can come provide effective therapy by themselves. Cancer cells have evolved numerous biological mechanisms that allow them to resist or overcome the effect of most drugs when used as a single agent. This has led […]